Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
17,781
18,021
18,169
17,827
17,156
17,313
Hasılat Artışı (YoY)
-1%
-1%
2%
4%
-1%
1%
Satınalma Maliyeti
10,048
9,264
10,146
10,595
9,895
9,320
Brüt Kâr
7,733
8,757
8,023
7,232
7,261
7,993
Satış, Genel ve İdari
4,990
5,068
5,132
5,280
4,717
4,551
Araştırma ve Geliştirme
1,745
1,747
1,890
2,103
1,705
1,691
İşletme Giderleri
6,649
7,798
7,616
7,372
6,303
6,150
Diğer Finansman Gelirleri (Giderleri)
--
-105
-83
-48
-10
-40
Kâr Öncesi Gelir
831
123
-526
-1,731
509
1,211
Kira Vergisi Gideri
658
963
-73
-113
-103
212
Net Kâr
165
-702
-466
-1,608
3,319
1,187
Net Income Growth
Kâr Artışı
-150%
51%
-71%
-148%
180%
2%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
963.84
933.37
948.78
952.45
982.74
957.56
Hisse Değişimi (Yıllık Üst Üste)
3%
-2%
0%
-3%
3%
3%
EPS (Diluted)
0.17
-0.75
-0.48
-1.7
3.37
1.23
EPS Artışı
-149%
56%
-72%
-151%
174%
-2%
Öz sermaye akışı
578
880
1,615
-991
4,269
1,745
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
43.49%
48.59%
44.15%
40.56%
42.32%
46.16%
Faaliyet Kâr Marjı
6.09%
5.32%
2.24%
-0.78%
5.58%
10.64%
Kâr Marjı
0.92%
-3.89%
-2.56%
-9.02%
19.34%
6.85%
Özsermaye Karlılık Oranı
3.25%
4.88%
8.88%
-5.55%
24.88%
10.07%
EBITDA
3,320
2,349
1,668
1,462
2,281
3,305
EBITDA Marjinali
18.67%
13.03%
9.18%
8.2%
13.29%
19.08%
D&A EBITDA için
2,236
1,390
1,261
1,602
1,323
1,462
Faaliyet Kârı
1,084
959
407
-140
958
1,843
Faaliyet Kâr Marjı
6.09%
5.32%
2.24%
-0.78%
5.58%
10.64%
Verilen Vergi Oranı
79.18%
782.92%
13.87%
6.52%
-20.23%
17.5%
Önemli İstatistikler
Önceki Kapanış
$28.54
Açılış fiyatı
$29.27
Günün Aralığı
$29.27 - $29.27
52 haftalık aralık
$21.27 - $30.19
İşlem hacmi
175
Ort.Hacim
2.3K
EPS (TTM)
0.19
Dividend yield
--
Piyasa Değeri
$28.1B
RYLPF nedir?
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,035 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.